NasdaqGM - Nasdaq Real Time Price USD

OmniAb, Inc. (OABI)

1.4950
-0.0250
(-1.64%)
As of 10:59:47 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
26,744
26,391
34,164
59,077
34,748
Operating Expense
97,537
100,893
103,583
85,725
70,357
Operating Income
-70,793
-74,502
-69,419
-26,648
-35,609
Net Non Operating Interest Income Expense
2,668
3,106
5,055
587
-7
Other Income Expense
--
-15
1
--
1,266
Pretax Income
-68,139
-71,411
-64,363
-26,061
-34,350
Tax Provision
-6,867
-9,378
-13,744
-3,727
-7,308
Net Income Common Stockholders
-61,272
-62,033
-50,619
-22,334
-27,042
Diluted NI Available to Com Stockholders
-61,272
-62,033
-50,619
-22,334
-27,042
Basic EPS
-0.59
--
-0.51
-0.26
-0.24
Diluted EPS
-0.59
--
-0.51
-0.26
-0.24
Basic Average Shares
103,581.7500
--
99,683
85,318
114,820.8590
Diluted Average Shares
103,581.7500
--
99,683
85,318
114,820.8590
Total Operating Income as Reported
-70,793
-74,502
-69,419
-26,648
-35,609
Total Expenses
97,537
100,893
103,583
85,725
70,357
Net Income from Continuing & Discontinued Operation
-61,272
-62,033
-50,619
-22,334
-27,042
Normalized Income
-61,272
-62,033
-50,619
-22,334
-27,042
Interest Income
2,668
3,106
5,055
587
0
Interest Expense
--
--
--
0
7
Net Interest Income
2,668
3,106
5,055
587
-7
EBIT
-70,793
-74,502
-69,419
-26,648
-34,343
EBITDA
-47,416
-50,919
-49,922
-8,399
-18,091
Reconciled Depreciation
23,377
23,583
19,497
18,249
16,252
Net Income from Continuing Operation Net Minority Interest
-61,272
-62,033
-50,619
-22,334
-27,042
Total Unusual Items Excluding Goodwill
291.7550
--
--
--
--
Total Unusual Items
291.7550
--
--
--
--
Normalized EBITDA
-47,416
-50,919
-49,922
-8,399
-18,091
Tax Rate for Calcs
0.0001
0.0001
0.0002
0.0001
0.0002
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 9/30/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

LGND Ligand Pharmaceuticals Incorporated
103.89
-1.15%
 
PVLA Palvella Therapeutics, Inc.
21.93
+1.06%
 
LXEO Lexeo Therapeutics, Inc.
2.4450
-9.11%
 
TVTX Travere Therapeutics, Inc.
20.96
-0.62%
 
VRCA Verrica Pharmaceuticals Inc.
0.5640
+5.35%
 
DSGN Design Therapeutics, Inc.
3.1900
-0.78%
 
ATXS Astria Therapeutics, Inc.
3.7500
-5.54%
 
DAWN Day One Biopharmaceuticals, Inc.
6.13
-0.97%
 
TERN Terns Pharmaceuticals, Inc.
2.6700
-3.96%
 
CNTX Context Therapeutics Inc.
0.7798
-1.29%